Funding for this research was provided by:
Received: 16 February 2022
Accepted: 30 September 2022
First Online: 15 October 2022
: This study was conducted in accordance with the international council for harmonization guidelines for Good Clinical Practice and the principles of Declaration of Helsinki. Additionally, it was conducted in accordance with the international society for pharmacoepidemiology (ISPE) guidelines for Good Epidemiology Practices.The study protocol, verbal informed consent and waiver of consent documentation were approved by Advarra Institutional Review Board.
: Not applicable.
: DA, SC, KT, and AM are employees of PRECISIONheor. DD and TM are employees of Bristol Myers Squibb, and may hold stock equity.